BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230908
DTSTAMP:20260516T071954
CREATED:20230515T131825Z
LAST-MODIFIED:20230515T131825Z
UID:37179-1693872000-1694131199@www.pharmajournalist.com
SUMMARY:5th Exosomes Based Therapeutic Development Summit
DESCRIPTION:The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program\, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications. \nThis year features a brand-new focus day on analytical development\, diving into characterization assays\, purification\, and potency assays to enable robust translation into the clinic. \nThis is the most comprehensive\, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes\, achieve GMP manufacturing of EVs for clinical applications\, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization. \nThe 2023 conference covers: \n\nEmerging standardized analytical strategies for optimized characterization\, purification\, and isolation to improve batch consistency and reproducibility towards successful scale-up\nKey pre-clinical and clinical updates across a range of therapeutic areas\nThe latest advancements of targeted delivery and therapeutic payloads\nThe challenges of large-scale manufacturing\nNavigating the complex regulatory landscape across the drug development timeline\n\nView the full agenda here: https://ter.li/q4fnpd
URL:https://www.pharmajournalist.com/event/5th-exosomes-based-therapeutic-development-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230908
DTSTAMP:20260516T071954
CREATED:20230519T095236Z
LAST-MODIFIED:20230519T095236Z
UID:37210-1693872000-1694131199@www.pharmajournalist.com
SUMMARY:4th Annual Gene Therapy Immunogenicity Summit 2023
DESCRIPTION:The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers\, along with leading academics\, regulators\, and key service providers\, all making strides with improving risk assessments\, monitoring\, and mitigating against AAV gene therapy immunogenicity. \nRegistering for 2023 will grant you access to keynote plenaries from leading gene therapy figures\, deep-dive discussions into pressing preclinical and clinical developments\, and highly appraised networking opportunities with 150+ of your peers\, all to leave you with the actionable tools\, insights\, and connections you need to enhance your immunogenicity-focused work. \nTo know more visit: https://ter.li/vk8xwq
URL:https://www.pharmajournalist.com/event/4th-annual-gene-therapy-immunogenicity-summit-2023/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230905
DTEND;VALUE=DATE:20230909
DTSTAMP:20260516T071954
CREATED:20230606T104920Z
LAST-MODIFIED:20230606T104920Z
UID:37280-1693872000-1694217599@www.pharmajournalist.com
SUMMARY:13th World Clinical Biomarkers & CDx Boston 2023
DESCRIPTION:The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization\, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster. \nWhether you are working in Oncology\, NASH\, or Neuroscience\, join 600+ Directors\, Heads and VPs of Clinical Biomarkers\, Translational Medicine\, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers\, regulatory experts\, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes. \nTo know more visit: https://ter.li/849j6q
URL:https://www.pharmajournalist.com/event/13th-world-clinical-biomarkers-cdx-boston-2023/
LOCATION:Omni Boston Hotel at the Seaport\, 450 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR